FR2805M - New drug in particular for the treatment of affections of bacterial origin. - Google Patents

New drug in particular for the treatment of affections of bacterial origin.

Info

Publication number
FR2805M
FR2805M FR939290A FR939290A FR2805M FR 2805 M FR2805 M FR 2805M FR 939290 A FR939290 A FR 939290A FR 939290 A FR939290 A FR 939290A FR 2805 M FR2805 M FR 2805M
Authority
FR
France
Prior art keywords
affections
treatment
new drug
bacterial origin
bacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR939290A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR929099A external-priority patent/FR1455763A/en
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR939290A priority Critical patent/FR2805M/en
Priority to CH341264A priority patent/CH425090A/en
Priority to DK137864A priority patent/DK123863B/en
Priority to SE338864A priority patent/SE329691B/xx
Priority to US353284A priority patent/US3423506A/en
Priority to NL646403153A priority patent/NL140513B/en
Priority to GB1265964A priority patent/GB1044258A/en
Priority to BE645676A priority patent/BE645676A/xx
Publication of FR2805M publication Critical patent/FR2805M/en
Application granted granted Critical
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/232Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with at least three saccharide radicals in the molecule, e.g. lividomycin, neomycin, paromomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
FR939290A 1963-03-25 1963-06-25 New drug in particular for the treatment of affections of bacterial origin. Active FR2805M (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR939290A FR2805M (en) 1963-03-25 1963-06-25 New drug in particular for the treatment of affections of bacterial origin.
CH341264A CH425090A (en) 1963-03-25 1964-03-17 Process for the preparation of a new derivative of neomycin B
DK137864A DK123863B (en) 1963-03-25 1964-03-18 Analogous process for the preparation of N-monophenylethylneomycin B or acid addition salts thereof.
SE338864A SE329691B (en) 1963-03-25 1964-03-18
US353284A US3423506A (en) 1963-03-25 1964-03-19 Mono-n-phenethyl neomycin b
NL646403153A NL140513B (en) 1963-03-25 1964-03-24 PROCESS FOR PREPARING A NEOMYCIN B DERIVATIVE WITH CHEMOTHERAPEUTIC ACTION.
GB1265964A GB1044258A (en) 1963-03-25 1964-03-25 N-substituted derivatives of neomycin b
BE645676A BE645676A (en) 1963-03-25 1964-03-25

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR929099A FR1455763A (en) 1963-03-25 1963-03-25 Neomycin b derivatives and method of preparation
FR939290A FR2805M (en) 1963-03-25 1963-06-25 New drug in particular for the treatment of affections of bacterial origin.

Publications (1)

Publication Number Publication Date
FR2805M true FR2805M (en) 1964-09-21

Family

ID=86605604

Family Applications (1)

Application Number Title Priority Date Filing Date
FR939290A Active FR2805M (en) 1963-03-25 1963-06-25 New drug in particular for the treatment of affections of bacterial origin.

Country Status (1)

Country Link
FR (1) FR2805M (en)

Similar Documents

Publication Publication Date Title
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3845M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.
FR3244M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2805M (en) New drug in particular for the treatment of affections of bacterial origin.
FR2969M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR2681M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1946M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR2974M (en) New drug in particular for the treatment of spasms of coronary origin and circulatory disorders.
FR3315M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3062M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR3126M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.